NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

體外診斷的全球市場:各零件,各技術,各終端用戶,各應用領域的預測(到2025年)- COVID-19累積的影響

In Vitro Diagnostics Market Research Report by Component, by Technology, by End User, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989825
出版日期 內容資訊 英文 186 Pages
商品交期: 最快1-2個工作天內
價格
體外診斷的全球市場:各零件,各技術,各終端用戶,各應用領域的預測(到2025年)- COVID-19累積的影響 In Vitro Diagnostics Market Research Report by Component, by Technology, by End User, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 186 Pages
簡介

全球體外診斷的市場規模,預計從2020年的562億6,606萬美元,擴大到2025年末達734億6,073萬美元。

本報告提供全球體外診斷市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19的影響,各零組件、技術、終端用戶、應用、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 規定事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場展望
  • 各零件市場展望
  • 各技術市場展望
  • 各應用領域市場展望
  • 各終端用戶市場展望
  • 各地區市場的展望
  • 其他競爭公司的展望

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各零件市場

  • 簡介
  • 資料管理軟體
  • 器具
  • 試劑和套件
  • 服務

第7章 各技術市場

  • 簡介
  • 臨床化學
    • 基本的代謝面板
    • 電解質面板
    • 脂質簡介
    • 肝面板
    • 腎臟簡介
    • 特殊化學實驗
    • 甲狀腺功能面板
  • 凝固與止血
  • 血液學
  • 免疫化學
    • 酵素免疫分析法
    • 酵素免疫分析法
    • 無線電免疫測量
    • 迅速檢驗
    • 西方印漬術
  • 微生物學
  • 分子診斷
    • DNA定序和次世代定序
    • 雜合反應
    • 恆溫核酸增幅技術
    • 微陣列
    • 聚合酵素鏈鎖反應
  • 尿液檢查

第8章 各終端用戶市場

  • 簡介
  • 醫院及照護供應商
  • 研究所
  • 患者的自診斷

第9章 各應用領域市場

  • 簡介
  • 自體免疫疾病
  • 心臟病
  • 糖尿病
  • 藥物檢驗
  • HIV/愛滋病
  • 感染疾病
  • 腎臟學
  • 腫瘤學

第10章 南北美洲市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章 歐洲,中東、非洲市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第14章 企業簡介

  • Biomerieux Sa
  • Danaher Corporation
  • Diasorin
  • Johnson & Johnson
  • Ortho Clinical Diagnostics
  • Qiagen
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific

第15章 附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-434CCDA04D40

The Global In Vitro Diagnostics Market size was estimated at USD 56.26 Billion in 2020 and expected to reach USD 59.62 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.31% to reach USD 81.25 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the In Vitro Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the In Vitro Diagnostics Market was studied across Data Management Software, Instruments, Reagents & Kits, and Services.

Based on Technology, the In Vitro Diagnostics Market was studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis. The Clinical Chemistry is further studied across Basic Metabolic Panel, Electrolyte Panel, Lipid Profile, Liver Panel, Renal Profile, Specialty Chemical Tests, and Thyroid Function Panel. The Immunochemistry is further studied across Enzyme-Linked Immunosorbent Assay, Enzyme-Linked Immunospot Assays, Radioimmunoassay, Rapid Test, and Western Blotting. The Molecular Diagnostics is further studied across DNA Sequencing & Next-Generation Sequencing, Hybridization, Isothermal Nucleic Acid Amplification Technology, Microarray, and Polymerase Chain Reaction.

Based on End User, the In Vitro Diagnostics Market was studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.

Based on Application, the In Vitro Diagnostics Market was studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.

Based on Geography, the In Vitro Diagnostics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the In Vitro Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In Vitro Diagnostics Market, including Biomerieux Sa, Danaher Corporation, Diasorin, Johnson & Johnson, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global In Vitro Diagnostics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global In Vitro Diagnostics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In Vitro Diagnostics Market?
  • 4. What is the competitive strategic window for opportunities in the Global In Vitro Diagnostics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global In Vitro Diagnostics Market?
  • 6. What is the market share of the leading vendors in the Global In Vitro Diagnostics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global In Vitro Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Component Outlook
  • 3.4. Technology Outlook
  • 3.5. Application Outlook
  • 3.6. End User Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
      • 5.1.1.2. Growing awareness on self-testing and personalized medicine
      • 5.1.1.3. Increasing adoption automated instruments and equipment in laboratories
      • 5.1.1.4. Increasing deployment of Point-of-Care testing facilities
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of condition-specific markers and tests
      • 5.1.3.2. Attractive companion diagnostics
      • 5.1.3.3. Growth opportunities in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Changing the regulatory landscape
      • 5.1.4.2. Operational limitations faced in conducting diagnostic tests
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. In Vitro Diagnostics Market, by Component

  • 6.1. Introduction
  • 6.2. Data Management Software
  • 6.3. Instruments
  • 6.4. Reagents & Kits
  • 6.5. Services

7. In Vitro Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Clinical Chemistry
    • 7.2.1. Basic Metabolic Panel
    • 7.2.2. Electrolyte Panel
    • 7.2.3. Lipid Profile
    • 7.2.4. Liver Panel
    • 7.2.5. Renal Profile
    • 7.2.6. Specialty Chemical Tests
    • 7.2.7. Thyroid Function Panel
  • 7.3. Coagulation & Hemostasis
  • 7.4. Hematology
  • 7.5. Immunochemistry
    • 7.5.1. Enzyme-Linked Immunosorbent Assay
      • 7.5.1.1. Chemiluminescence Immunoassays
      • 7.5.1.2. Colorimetric Immunoassays
      • 7.5.1.3. Fluorescence Immunoassays
    • 7.5.2. Enzyme-Linked Immunospot Assays
    • 7.5.3. Radioimmunoassay
    • 7.5.4. Rapid Test
    • 7.5.5. Western Blotting
  • 7.6. Microbiology
  • 7.7. Molecular Diagnostics
    • 7.7.1. DNA Sequencing & Next-Generation Sequencing
    • 7.7.2. Hybridization
    • 7.7.3. Isothermal Nucleic Acid Amplification Technology
    • 7.7.4. Microarray
    • 7.7.5. Polymerase Chain Reaction
  • 7.8. Urinalysis

8. In Vitro Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals & Care Providers
  • 8.3. Laboratories
  • 8.4. Patient Self-Testing

9. In Vitro Diagnostics Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
  • 9.3. Cardiology
  • 9.4. Diabetes
  • 9.5. Drug Testing
  • 9.6. HIV/Aids
  • 9.7. Infectious Diseases
  • 9.8. Nephrology
  • 9.9. Oncology

10. Americas In Vitro Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific In Vitro Diagnostics Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa In Vitro Diagnostics Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Biomerieux Sa
  • 14.2. Danaher Corporation
  • 14.3. Diasorin
  • 14.4. Johnson & Johnson
  • 14.5. Ortho Clinical Diagnostics
  • 14.6. Qiagen
  • 14.7. Roche Diagnostics
  • 14.8. Siemens AG
  • 14.9. Sysmex Corporation
  • 14.10. Thermo Fisher Scientific

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 7. GLOBAL IN VITRO DIAGNOSTICS MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL IN VITRO DIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2026
  • FIGURE 12. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 23. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, 2018-2026 (USD BILLION)
  • FIGURE 50. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, 2018-2026 (USD BILLION)
  • FIGURE 52. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 53. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, 2018-2026 (USD BILLION)
  • FIGURE 54. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 55. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2026 (USD BILLION)
  • FIGURE 56. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 57. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2026 (USD BILLION)
  • FIGURE 58. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 59. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, 2018-2026 (USD BILLION)
  • FIGURE 60. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 61. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 62. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 63. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD BILLION)
  • FIGURE 64. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 65. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, 2018-2026 (USD BILLION)
  • FIGURE 66. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 67. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, 2018-2026 (USD BILLION)
  • FIGURE 68. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 69. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 70. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 71. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2026 (USD BILLION)
  • FIGURE 72. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 73. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2026 (USD BILLION)
  • FIGURE 74. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 75. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, 2018-2026 (USD BILLION)
  • FIGURE 76. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 77. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 78. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 79. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2026
  • FIGURE 80. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2026 (USD BILLION)
  • FIGURE 81. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 82. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2026 (USD BILLION)
  • FIGURE 83. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 84. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, 2018-2026 (USD BILLION)
  • FIGURE 85. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 86. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 87. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 88. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 89. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 90. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 91. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 92. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 93. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
  • FIGURE 94. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 95. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, 2018-2026 (USD BILLION)
  • FIGURE 96. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 97. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, 2018-2026 (USD BILLION)
  • FIGURE 98. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 99. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 100. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 101. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, 2018-2026 (USD BILLION)
  • FIGURE 102. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 103. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 104. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 105. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 106. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 107. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 108. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 109. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 110. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 111. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 112. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 113. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 114. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 115. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 116. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 117. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 118. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 119. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 120. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 121. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 122. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 123. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 124. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 125. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 126. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 127. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 128. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 129. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 130. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 131. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 132. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 133. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 134. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 135. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 136. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 137. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 138. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 139. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 140. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 141. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 142. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 143. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 144. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 145. GLOBAL IN VITRO DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 146. GLOBAL IN VITRO DIAGNOSTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 147. GLOBAL IN VITRO DIAGNOSTICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 148. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL IN VITRO DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. AMERICAS IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. ARGENTINA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. BRAZIL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. CANADA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. MEXICO IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. UNITED STATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. CALIFORNIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. FLORIDA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. ILLINOIS IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. NEW YORK IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. OHIO IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. PENNSYLVANIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. TEXAS IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. CHINA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. INDIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. INDONESIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. JAPAN IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 125. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 127. MALAYSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 128. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 129. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 130. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 131. PHILIPPINES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 132. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 133. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 134. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 135. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 136. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 137. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 138. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 139. THAILAND IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 145. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 146. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 147. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 148. FRANCE IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 149. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 150. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 151. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 152. GERMANY IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 153. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 154. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 155. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 156. ITALY IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 157. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 158. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 159. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 160. NETHERLANDS IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 161. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 162. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 163. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 164. QATAR IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 165. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 166. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 167. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 168. RUSSIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 169. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 170. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 171. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 172. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 173. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 174. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 175. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 176. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 177. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 178. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 179. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 180. SPAIN IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 181. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 182. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 183. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 184. UNITED ARAB EMIRATES IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 185. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 186. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 187. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 188. UNITED KINGDOM IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 189. GLOBAL IN VITRO DIAGNOSTICS MARKET: SCORES
  • TABLE 190. GLOBAL IN VITRO DIAGNOSTICS MARKET: BUSINESS STRATEGY
  • TABLE 191. GLOBAL IN VITRO DIAGNOSTICS MARKET: PRODUCT SATISFACTION
  • TABLE 192. GLOBAL IN VITRO DIAGNOSTICS MARKET: RANKING
  • TABLE 193. GLOBAL IN VITRO DIAGNOSTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 194. GLOBAL IN VITRO DIAGNOSTICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 195. GLOBAL IN VITRO DIAGNOSTICS MARKET: MERGER & ACQUISITION
  • TABLE 196. GLOBAL IN VITRO DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 197. GLOBAL IN VITRO DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 198. GLOBAL IN VITRO DIAGNOSTICS MARKET: INVESTMENT & FUNDING
  • TABLE 199. GLOBAL IN VITRO DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 200. GLOBAL IN VITRO DIAGNOSTICS MARKET: LICENSE & PRICING
  • TABLE 201. GLOBAL IN VITRO DIAGNOSTICS MARKET: CONTACT DETAILS